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ABSTRACT
Osteoporosis is a disease characterized by low bone mass and micro
architectural alterations of bone tissue leading to enhanced bone fragili-
ty and increased fracture risk. Although research in osteoporosis has
focused mainly on the role of bone loss in the elderly population, it is
becoming increasingly clear that the amount of bone that is gained dur-
ing growth is also an important determinant of future resistance to frac-
tures. Thus, considerable interest is being placed on defining preventive
strategies that optimize the gain of bone mass during childhood and
adolescence. Knowledge of the determinants accounting for the physi-
ologic and genetic variations in bone accumulation in children will pro-
vide the best means toward the early diagnosis and treatment of osteo-
porosis. This article reviews the techniques available for bone mass mea-
surements in children and the major determinants and diseases influenc-
ing bone accretion during childhood and adolescence. (Arq Bras
Endocrinol Metab 2006;50/4:775-782)
Keywords: Low bone mass; Bone mass measurement; DXA in childhood
and adolescence; Update; Controversy
RESUMO
Baixa Massa Óssea em Crianças e Adolescentes.
Osteoporose é uma doença caracterizada pela baixa massa óssea e
alterações de micro arquitetura do tecido ósseo, levando ao aumento
da fragilidade óssea e aumento do risco de fratura. Apesar da pesquisa
em osteoporose ter focalizado principalmente no papel da perda óssea
na população idosa, está começando a ficar claro que a quantidade
de osso que é ganho durante o crescimento é também um determi-
nante importante de resistência futura para fraturas. Portanto, interesse
considerável está sendo colocado na definição de estratégias preven-
tivas que otimizam o ganho de massa óssea durante a infância e ado-
lescência. O conhecimento dos determinantes responsáveis pelas vari-
ações fisiológicas e genéticas, na acumulação óssea nas crianças, irá
levar aos melhores meios para o diagnóstico precoce e tratamento da
osteoporose. Este artigo revê as técnicas disponíveis para a medida da
massa óssea em crianças e os maiores determinantes e doenças que
influenciam a aquisição óssea durante a infância e adolescência. (Arq
Bras Endocrinol Metab 2006;50/4:775-782)
Descritores: Baixa massa óssea; Medidas da massa óssea; DXA na infân-
cia e adolesência; Atualização em DXA; Controvérsia em DXA
original articleLow Bone Mass in Children and Adolescents
João Lindolfo C. Borges
Cynthia M.A. Brandão
Universidade Católica de Brasília,
DF (JLCB); and Division of
Endocrinology, Federal University
of São Paulo (UNIFESP/EPM)
and Fleury — Diagnostic 
Medicine, São Paulo, SP 
(CMAB), Brazil.
Received in 05/01/06
Accepted in 05/20/06
Low Bone Mass in Children and Adolescents
Borges & Brandão
776 Arq Bras Endocrinol Metab vol 50 nº 4 Agosto 2006
THE PEAK BONE MASS
THE FOUNDATION FOR LIFELONG skeletal health isestablished during childhood and adolescence.
Although there is controversy regarding the exact tim-
ing of peak bone mass, bone size and strength reach a
maximum by early adulthood (1-3). Failure to accrue
optimal peak bone mass has been linked to an
increased risk of osteoporosis (4). The variables that
contribute to optimal bone health have been delineat-
ed in studies of healthy youth (1-3).
Approximately 90% of adult bone mass is
gained in the first two decades of life. Optimizing peak
bone mass and bone strength early in life and stabiliz-
ing it during young adulthood is believed to play a sig-
nificant role in preventing osteoporosis and fractures
later in life. Adequate weight-bearing physical activity,
nutrition, body mass, and hormonal balance are essen-
tial in achieving optimal skeletal health. A growing list
of chronic diseases has also been linked to low bone
mass or fragility fractures (5-30). Disorders causing
rickets and osteomalacia are reviewed by Durval else-
where in this issue. In some chronic conditions, a sin-
gle factor (e.g., immobilization or hypogonadism)
accounts for the increased risk of low bone mass. In
most of these disorders, however, skeletal health is
threatened by a combination of risk factors including
malnutrition, vitamin D insufficiency, malabsorption,
deficiency or resistance to sex steroids or growth hor-
mone, immobilization, and increased cytokine pro-
duction. Medications that are used to treat these dis-
orders, such as glucocorticoids, calcineurin inhibitors,
and chemotherapeutic agents, may also contribute to
bone loss (6). The magnitude of effect that these dis-
orders or medications will have on an individual
patient varies, depending upon genetic factors, disease
severity, activity, and other variables. For this reason,
clinicians seek diagnostic tools to identify patients at
greatest risk for bone fragility.
Obese and less-active children also have been
shown to have decreased BMD or bone mass compared
with non-obese children of similar weight (31,32). It is
not clear whether this decreased BMD among obese chil-
dren is a direct effect of fat on bone or due to decreased
muscle mass or reduced activity levels, or a combination
of both of these factors. However, the epidemic of child-
hood obesity may in part directly or indirectly explain the
increase in childhood fracture incidence that has recently
been reported (33). Identifying children with low bone
mass early in life could be an important strategy for pre-
ventative or therapeutic efforts to optimize bone accrual
and, consequently, bone strength (table 1).
ASSESSING PEDIATRIC BONE HEALTH
DXA is the most widely used densitometric method
for diagnosing osteoporosis in adults. DXA was devel-
oped in the late 1980s for use primarily in post-
menopausal women. Pediatric software became avail-
able in the early 1990s after improvements in algo-
rithms for detecting bone edges in children with low
bone density. The advantages of DXA are its wide
availability, short scanning times, and relatively low
radiation exposure. The radiation exposure is compa-
rable to that received during a round trip transconti-
nental airplane flight. DXA has several important limi-
tations, however (34-36). The technique does not
provide a measure of volumetric bone mineral density
Table 1. Disorders associated with low bone mass or frac-
tures in childhood and adolescence (60).
Genetic disorders (6,42)
Ehlers-Danlos
Fibrous dysplasia
Homocystinuria
Hypophosphatasia
Idiopathic hypercalciuria
Marfan's syndrome
Menkes' kinky hair syndrome
Osteogenesis imperfecta
Chronic disease
Anorexia nervosa (7,8)
Athletic amenorrhea (9)
Celiac disease (10)
Cystic fibrosis (11)
Diabetes (type I) (12)
Hematologic thalassemia, sickle-cell anemia (13)
Inflammatory bowel disease (14)
Malignancy (15-17)
Post transplantation (18)
Renal failure (19)
Rheumatologic disorders (20)
Endocrine disorders
Glucocorticoid excess (21)
Growth hormone deficiency (22)
Hyperparathyroidism (23)
Hyperthyroidism (26)
Sex steroid deficiency or resistance (25,26)
Immobilization
Cerebral palsy (27)
Muscular dystrophy (28)
Paraplegia
Spina bifida
Miscellaneous
Idiopathic juvenile osteoporosis (29)
Idiopathic scoliosis (30)
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or of bone geometry nor does it distinguish between
cortical and trabecular bone. Although bone size and
geometry can be adjusted for mathematically, these are
only estimates of these parameters. Because this is a 2-
dimensional measurement and not a true volumetric
density, measurements using DXA are often referred
to as areal BMD (aBMD). Measurements of aBMD
are influenced by bone size, with larger bones having
artificially inflated aBMD measurements (figure 1).
This is an important problem in pediatric bone assess-
ment because of the large differences in body size and
bone size within and across different ages. Studies
show that aBMD by DXA increases with age, but com-
puted tomography evaluations indicate that true volu-
metric BMD (vBMD) is relatively constant during
childhood until puberty, at which time there is a large
increase in vBMD (37). BMC increases with age, and
the increase in aBMD that is observed is likely the
result of greater bone size.
Although adult aBMD has been shown to be
predictive of future fracture risk in longitudinal epi-
demiologic studies (Data on the Bone Densitometry
Chapter), there is no evidence indicating this in chil-
dren. The aBMD results are often presented as T- and
Z-scores. Because T-scores compare the observed
aBMD with that of young adults, they are not appro-
priate for growing children and should never be used.
Z-scores, defined as the SD score based on age and
gender-specific norms, must be used to determine how
a child’s aBMD compares with other children’s (figures
2 and 3). This is a more appropriate method of com-
parison of aBMD in pediatrics. As previously described,
however, aBMD is highly correlated to body and bone
size, and in children with chronic diseases in whom
weight or height for age may be severely affected, the
comparison of aBMD measurements to age-matched
norms is difficult to interpret.
Total body and lumbar spine (L1-L4) DXA scans
are reported in pediatric studies. Total body is a pre-
dominantly cortical bone measurement while lumbar
spine is mainly trabecular bone. Thus different skeletal
sites will be affected by different factors. Dietary calcium
intake has been shown to affect primarily appendicular
bone sites that are predominantly cortical bone (38),
whereas hypogonadism and steroid use affect primarily
axial bone sites or the ends of long bones, which are
predominantly trabecular bones (39,40).
Although regional DXA scans can measure
BMD and BMC at sites that are predominantly tra-
becular or cortical bone, it is not possible to obtain
separate cortical and trabecular BMD results using
DXA. The aBMD assessed by DXA is a function of
both the amount of bone within the periosteal enve-
lope and the size of the bone.
Figure 1. Areal BMD measurements are influenced by bone size, with larger bones of similar volu-
metric BMD having higher areal BMD values.
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BONE MASS MEASUREMENT GENERAL 
GUIDELINES
There are currently no standard recommendations by
either a U.S. pediatric or bone organization regard-
ing who should have bone measurements for clinical
purposes. The British Paediatric and Adolescent
Bone Group recently published pediatric guidelines
for the clinical use of DXA (41). They suggested that
children with conditions that may increase their risk
of low bone density and fracture should be consid-
ered for a DXA scan if they also present low trauma
or recurrent fractures, back pain, spinal deformity or
loss of height, change in mobility status, or malnutri-
tion. The list of conditions that place children at
increased risk is given in table 1, along with some of
the more rare conditions that also may be associated
with decreased BMD. Because of the lack of pediatric
reference databases, the variation between machines,
and the different software analyses that are per-
formed, it is important that clinicians consult with
pediatric bone specialists before using DXA diagnos-
tically or prescribing treatment on the basis of DXA
methods.
The International Society of Clinical Densitom-
etry recently published an official position paper on
recommendations for performance and clinical appli-
cation of bone density testing, which included recom-
mendations specific for diagnosis in children (table 2).
INTERPRETING PEDIATRIC DUAL-ENERGY X-RAY
Interpreting bone mineral measurements is far more
complex in children than in adults and goes beyond cal-
culating a Z-score (34,36,43,44). Unlike the adult
whose bone dimensions are stable with time, children
and adolescents are moving targets whose bone size,
geometry, and mineral content are changing. These
processes evolve at varying rates in different regions of
the skeleton, with appendicular growth preceding spinal
mineral acquisition (44). Furthermore, within a given
Figure 2. Shows the different graphs for the interpretation of bone densitometry. Pediatric bone densi-
ty is compared for patients of the same age, the Z-score. Adult bone density is read comparing young
adults, 20 to 40 years old, density, and T-score.
Figure 3. Spine and total body scan of a 11-year-old girl, 40,1 kg, 142,0 cm height, referred to evalua-
tion for previous use of anticonvulsants for five years. Her BMI is 20, at the 80 th percentile for age,
according to CDC Growth Charts, and Tanner Stage B2P2, no menarche. The Z-score for total skele-
tal is -0,6 and for lumbar spine (L1L4) is -1,4. The diagnosis is "adequate bone mass density for chrono-
logical age" since the Z-score values are less than -2,0 within the normal pediatric range.
Referência: L1-L4
BMD (g/cm2
Idade (anos)
Referência: L1-L4
BMD (g/cm2
Idade (anos)
Referência: L1-L4
BMD (g/cm2
Idade (anos)
Referência: L1-L4
BMD (g/cm2 YA T-Score
Idade (anos)
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region of interest, trabecular and cortical compartments
respond variably to sex steroids, calcium intake, and
mechanical loading. The tempo of mineral accrual is
linked more closely to pubertal and skeletal maturation
than to chronologic age, and these processes vary with
gender and ethnicity (43,44,45,49,50). For this reason,
the influence of bone size and maturation must be con-
sidered in evaluating DXA results.
In fact it is very important to correlate bone
acquisition in young subjects not only with chrono-
logical age or sex, as it is done in commercial soft-
wares, but also with anthropometrical parameters, par-
ticularly in longitudinal evaluations. On the basis of
many studies published on literature (45-48), the
pubertal development and weight are the most impor-
tant parameters in monitoring bone mass in adoles-
cents. When children have delayed growth or puberty
and altered body composition, these factors must be
considered in interpreting BMC and BMD. For chil-
dren with delayed growth and maturation, it is also
reasonable to adjust for pubertal stage rather than for
chronological age. Unfortunately, only a few studies
have reported normative data by pubertal stage
(16,44,51). Alternatively, a bone age can be obtained
and BMD data compared with norms for the patient’s
skeletal rather than chronological age.
Additionally, BMC and BMD are strongly
influenced by bone size; BMD corrects only for the
area of bone studied but not the thickness of bone.
For this reason, true (volumetric) bone density may be
underestimated in patients with smaller bones and
overestimated in larger children. Several methods have
been proposed to adjust bone mass for the influence of
bone size or lean body mass (52-55). Estimates of vol-
umetric bone density at the spine and femoral neck
divide BMC by the estimated volume of bone in the
region; total body BMC is corrected for relative height
(55). None of these correction models has been estab-
lished as best by the gold standard of predicting child-
hood fracture. Furthermore, given two bones of equal
density, the larger bone will be more resistant to frac-
ture than the smaller one. Nonetheless, it is possible to
estimate how much reduced BMD can be attributed
to smaller bone size by calculating volumetric BMD.
Limited pediatric norms for volumetric BMD have
been published (49,55-57). An example of a pediatric
DXA interpretation is provided in figure 2.
INTERPRETING LOW BONE MASS
The fracture risk associated with low BMD is far less
certain in children and young adults. Patients with
mild forms of osteogenesis imperfecta (OI), for exam-
ple, have very low BMD but do not suffer spontaneous
fractures. The International Society for Clinical Den-
sitometry has determined that the diagnosis of osteo-
porosis in a young patient “should not be made on the
basis of densitometric criteria alone”. The WHO crite-
ria for osteopenia and osteoporosis are not appropriate
for use in children, adolescents, and young adults.
Terms such as “low bone density for chronologic age”
may be used if the Z-score is less than -2.0; the term
“osteoporosis” must be avoided since it is better con-
ditions of loss of bone. By implication, the diagnosis of
“low bone density for chronologic age” in a child
requires additional clinical findings such as a history of
low impact fracture.
Finding low bone mass on a pediatric DXA
does not necessarily imply bone loss. Low bone mass
Table 2. Position of the International Society for Clinical Densitometry (ISCD) on the Use of DXA in Diagnosis in Chil-
dren (males or females less than 20 years of age) (32).
• The WHO classification (for defining osteopenia and osteoporosis) should not be used.
• Z-scores should be used instead of T-scores in children.
• T-scores should not appear in reports or on DXA printouts for children.
• The diagnosis of osteoporosis in children should not be made on the basis of densitometric criteria alone.
• Terminology such as "low bone density for chronological age" may be used if the Z-score is below -2.0.
• Z-scores must be interpreted in light of the best available pediatric databases of age-matched controls. The
reference database should be cited in the report.
• Preferred skeletal sites for measurement are spine and total body.
• The value of BMD to predict fractures in children is not clearly demonstrated.
• Standards for adjusting BMD or bone mineral content (BMC) for factors such as bone size, pubertal stage, skele-
tal maturity, or body composition have not been agreed upon. Clearly state any adjustments in the report.
• Successive BMD studies should be done using the same machine, scanning mode, software, and analysis when
appropriate. Changes may be required with growth of the child.
• Deviations from standard adult acquisition protocols, for example low-density software or any adjustment of
ROI (region of interest), should be stated in the report.
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in a child can result from inadequate gains of bone
mineral, bone loss, or a combination of the two
(8,58,59). Understanding this is critical, because most
drugs used to treat osteoporosis in adults are anticata-
bolic agents that reduce bone loss. Children who fail
to gain adequate bone mineral may require therapy
that is anabolic or bone building. It is beyond the
scope of this article to review the current therapies for
pediatric low bone mass (5,6). At the very minimum,
however, the finding of low bone mass should prompt
a search for possible cause(s), including a review of
overall nutrition, calcium intake, vitamin D stores
(serum 25 hydroxyvitamin D), hormonal status, phys-
ical activity, and underlying disease status. All risk fac-
tors should be addressed.
CONCLUSIONS
Bone acquisition early in life is considered an important
predictor of osteoporosis risk later in life. DXA is the
most common method for assessing bone health in pedi-
atric populations. There are, however, several problems
with interpreting DXA scans in children that need to be
considered by clinicians before therapeutic interventions
are implemented on the basis of DXA results. PQCT is a
promising method that is currently being used in pedi-
atric bone research that may find its way into clinical use
for assessing bone strength and fracture risk. Further
research is needed to determine whether QUS could be
used as a radiation-free alternative for assessing bone
development clinically and in epidemiologic studies.
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